{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:26:23Z","timestamp":1785277583347,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010909","name":"Young Scientists Fund","doi-asserted-by":"publisher","award":["81900534"],"award-info":[{"award-number":["81900534"]}],"id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2018A030313398"],"award-info":[{"award-number":["2018A030313398"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Alcoholism is a well-known risk factor for liver injury and is one of the major causes of hepatic steatosis worldwide. Although many drugs have been reported to have protective effects against acute alcohol-induced hepatotoxicity, there is limited available treatment for alcoholic liver disease (ALD), indicating an urgent need for effective therapeutic options. Herein, we first reported the protective effects of magnesium isoglycyrrhizinate (MgIG) on acute alcohol-induced hepatic steatosis and its related mechanisms in a zebrafish model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Alcohol was administered directly to embryo medium at 5\u00a0days post-fertilization (dpf) for up to 32\u00a0h. MgIG was given to the larvae 2\u00a0h before the administration of alcohol and then cotreated with alcohol starting at 5\u00a0dpf. Oil red O staining was used to determine the incidence of steatosis, and pathological features of the liver were assessed by hematoxylin\u2013eosin staining. Biological indexes, total cholesterol (TC) and triacylglycerol (TG) were detected in the livers of zebrafish larvae. Morphological changes in the livers of zebrafish larvae were observed using liver-specific EGFP transgenic zebrafish (Tg(<jats:italic>lfabp10a:eGFP<\/jats:italic>)). The expression levels of critical molecules related to endoplasmic reticulum (ER) stress and lipid metabolism were detected by qRT\u2013PCR, whole-mount in situ hybridization and western blotting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Alcohol-treated larvae developed hepatomegaly and steatosis after 32\u00a0h of exposure. We found that MgIG improved hepatomegaly and reduced the incidence of steatosis in a dose-dependent manner by oil red O staining and diminished deposits of alcohol-induced fat droplets by histologic analysis. Moreover, MgIG significantly decreased the levels of TC and TG in the livers of zebrafish larvae. Furthermore, the expression levels of critical genes involved in ER stress (<jats:italic>atf6<\/jats:italic>, <jats:italic>irela<\/jats:italic>, <jats:italic>bip<\/jats:italic>, <jats:italic>chop<\/jats:italic>) and the key enzymes regulating lipid metabolism (<jats:italic>acc1, fasn, hmgcs1<\/jats:italic> and <jats:italic>hmgcra<\/jats:italic>) were significantly higher in the alcohol-treated group than in the control group. However, in the MgIG plus alcohol-treated group, the expression of these genes was markedly decreased compared with that in the alcohol-treated group. Whole-mount in situ hybridization and western blotting also showed that MgIG had an effect on the expression levels of critical genes and proteins involved in lipid metabolism and ER stress. Our results revealed that MgIG could markedly regulate these genes and protect the liver from ER stress and lipid metabolism disorders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study is the first to demonstrate that MgIG could protect the liver from acute alcohol stimulation by ameliorating the disorder of lipid metabolism and regulating ER stress in zebrafish larvae.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12986-022-00655-7","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T11:36:16Z","timestamp":1648208176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Magnesium isoglycyrrhizinate attenuates acute alcohol-induced hepatic steatosis in a zebrafish model by regulating lipid metabolism and ER stress"],"prefix":"10.1186","volume":"19","author":[{"given":"Wencong","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchun","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5265-4159","authenticated-orcid":false,"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"655_CR1","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","volume":"141","author":"B Gao","year":"2011","unstructured":"Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011;141:1572\u201385.","journal-title":"Gastroenterology"},{"key":"655_CR2","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1016\/S0140-6736(09)60746-7","volume":"373","author":"J Rehm","year":"2009","unstructured":"Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373:2223\u201333.","journal-title":"Lancet"},{"key":"655_CR3","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.freeradbiomed.2007.12.029","volume":"44","author":"SK Mantena","year":"2008","unstructured":"Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM. Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol Med. 2008;44:1259\u201372.","journal-title":"Free Radic Biol Med"},{"key":"655_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1530-0277.2011.01602.x","volume":"36","author":"DL Howarth","year":"2012","unstructured":"Howarth DL, Vacaru AM, Tsedensodnom O, Mormone E, Nieto N, Costantini LM, Snapp EL, Sadler KC. Alcohol disrupts endoplasmic reticulum function and protein secretion in hepatocytes. Alcohol Clin Exp Res. 2012;36:14\u201323.","journal-title":"Alcohol Clin Exp Res"},{"key":"655_CR5","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1056\/NEJM196804182781602","volume":"278","author":"E Rubin","year":"1968","unstructured":"Rubin E, Lieber CS. Alcohol-induced hepatic injury in nonalcoholic volunteers. N Engl J Med. 1968;278:869\u201376.","journal-title":"N Engl J Med"},{"key":"655_CR6","first-page":"1213","volume":"6","author":"O Tsedensodnom","year":"2013","unstructured":"Tsedensodnom O, Vacaru AM, Howarth DL, Yin C, Sadler KC. Ethanol metabolism and oxidative stress are required for unfolded protein response activation and steatosis in zebrafish with alcoholic liver disease. Dis Model Mech. 2013;6:1213\u201326.","journal-title":"Dis Model Mech"},{"key":"655_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/hep.24396","volume":"54","author":"A Cinaroglu","year":"2011","unstructured":"Cinaroglu A, Gao C, Imrie D, Sadler KC. Activating transcription factor 6 plays protective and pathological roles in steatosis due to endoplasmic reticulum stress in zebrafish. Hepatology. 2011;54:495\u2013508.","journal-title":"Hepatology"},{"key":"655_CR8","doi-asserted-by":"publisher","first-page":"513797","DOI":"10.1155\/2014\/513787","volume":"2014","author":"C Ji","year":"2014","unstructured":"Ji C. New insights into the pathogenesis of alcohol-induced ER stress and liver diseases. Int J Hepatol. 2014;2014:513797.","journal-title":"Int J Hepatol"},{"key":"655_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jhep.2010.11.005","volume":"54","author":"H Malhi","year":"2011","unstructured":"Malhi H, Kaufman RJ. Endoplasmic reticulum stress in liver disease. J Hepatol. 2011;54:795\u2013809.","journal-title":"J Hepatol"},{"key":"655_CR10","doi-asserted-by":"publisher","first-page":"216450","DOI":"10.1155\/2012\/216450","volume":"2012","author":"C Ji","year":"2012","unstructured":"Ji C. Mechanisms of alcohol-induced endoplasmic reticulum stress and organ injuries. Biochem Res Int. 2012;2012:216450.","journal-title":"Biochem Res Int"},{"key":"655_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1194\/jlr.R119000547","volume":"61","author":"S Jeon","year":"2020","unstructured":"Jeon S, Carr R. Alcohol effects on hepatic lipid metabolism. J Lipid Res. 2020;61:470\u20139.","journal-title":"J Lipid Res"},{"key":"655_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2018.10.037","volume":"70","author":"M You","year":"2019","unstructured":"You M, Arteel GE. Effect of ethanol on lipid metabolism. J Hepatol. 2019;70:237\u201348.","journal-title":"J Hepatol"},{"key":"655_CR13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/acer.12011","volume":"37","author":"SD Shukla","year":"2013","unstructured":"Shukla SD, Pruett SB, Szabo G, Arteel GE. Binge ethanol and liver: new molecular developments. Alcohol Clin Exp Res. 2013;37:550\u20137.","journal-title":"Alcohol Clin Exp Res"},{"key":"655_CR14","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1111\/liv.13482","volume":"37","author":"M Ventura-Cots","year":"2017","unstructured":"Ventura-Cots M, Watts AE, Bataller R. Binge drinking as a risk factor for advanced alcoholic liver disease. Liver Int. 2017;37:1281\u20133.","journal-title":"Liver Int"},{"key":"655_CR15","doi-asserted-by":"publisher","first-page":"e1004335","DOI":"10.1371\/journal.pgen.1004335","volume":"10","author":"DL Howarth","year":"2014","unstructured":"Howarth DL, Lindtner C, Vacaru AM, Sachidanandam R, Tsedensodnom O, Vasilkova T, Buettner C, Sadler KC. Activating transcription factor 6 is necessary and sufficient for alcoholic fatty liver disease in zebrafish. PLoS Genet. 2014;10:e1004335.","journal-title":"PLoS Genet"},{"key":"655_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jphs.2018.08.007","volume":"138","author":"Y Lai","year":"2018","unstructured":"Lai Y, Zhou C, Huang P, Dong Z, Mo C, Xie L, Lin H, Zhou Z, Deng G, Liu Y, et al. Polydatin alleviated alcoholic liver injury in zebrafish larvae through ameliorating lipid metabolism and oxidative stress. J Pharmacol Sci. 2018;138:46\u201353.","journal-title":"J Pharmacol Sci"},{"key":"655_CR17","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.3892\/or.2017.5965","volume":"38","author":"H Lin","year":"2017","unstructured":"Lin H, Zhou Z, Zhong W, Huang P, Ma N, Zhang Y, Zhou C, Lai Y, Huang S, An H, et al. Naringenin inhibits alcoholic injury by improving lipid metabolism and reducing apoptosis in zebrafish larvae. Oncol Rep. 2017;38:2877\u201384.","journal-title":"Oncol Rep"},{"key":"655_CR18","doi-asserted-by":"publisher","first-page":"111121","DOI":"10.1016\/j.biopha.2020.111121","volume":"134","author":"YS Liu","year":"2021","unstructured":"Liu YS, Yuan MH, Zhang CY, Liu HM, Liu JR, Wei AL, Ye Q, Zeng B, Li MF, Guo YP, Guo L. Puerariae Lobatae radix flavonoids and puerarin alleviate alcoholic liver injury in zebrafish by regulating alcohol and lipid metabolism. Biomed Pharmacother. 2021;134:111121.","journal-title":"Biomed Pharmacother"},{"key":"655_CR19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/hep.22667","volume":"49","author":"MJ Passeri","year":"2009","unstructured":"Passeri MJ, Cinaroglu A, Gao C, Sadler KC. Hepatic steatosis in response to acute alcohol exposure in zebrafish requires sterol regulatory element binding protein activation. Hepatology. 2009;49:443\u201352.","journal-title":"Hepatology"},{"key":"655_CR20","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nrg892","volume":"3","author":"DJ Grunwald","year":"2002","unstructured":"Grunwald DJ, Eisen JS. Headwaters of the zebrafish\u2014emergence of a new model vertebrate. Nat Rev Genet. 2002;3:717\u201324.","journal-title":"Nat Rev Genet"},{"key":"655_CR21","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1530-0277.2010.01407.x","volume":"35","author":"DL Howarth","year":"2011","unstructured":"Howarth DL, Passeri M, Sadler KC. Drinks like a fish: using zebrafish to understand alcoholic liver disease. Alcohol Clin Exp Res. 2011;35:826\u20139.","journal-title":"Alcohol Clin Exp Res"},{"key":"655_CR22","first-page":"872139","volume":"2014","author":"JY Li","year":"2014","unstructured":"Li JY, Cao HY, Liu P, Cheng GH, Sun MY. Glycyrrhizic acid in the treatment of liver diseases: literature review. Biomed Res Int. 2014;2014:872139.","journal-title":"Biomed Res Int"},{"key":"655_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s13318-013-0136-y","volume":"39","author":"KJ Chen","year":"2014","unstructured":"Chen KJ, Chen WY, Chen X, Jia YM, Peng GQ, Chen L. Increased elimination of paclitaxel by magnesium isoglycyrrhizinate in epithelial ovarian cancer patients treated with paclitaxel plus cisplatin: a pilot clinical study. Eur J Drug Metab Pharmacokinet. 2014;39:25\u201331.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"655_CR24","first-page":"847","volume":"17","author":"YM Mao","year":"2009","unstructured":"Mao YM, Zeng MD, Chen Y, Chen CW, Fu QC, Cai X, Wu SM, Chen YG, Sun Y, Li J, et al. Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases: a randomized, double-blind, multi-doses, active drug controlled, multi-center study. Zhonghua Gan Zang Bing Za Zhi. 2009;17:847\u201351.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"655_CR25","first-page":"537","volume":"20","author":"JC Zhang","year":"2012","unstructured":"Zhang JC, Zheng GF, Wu MX, Wu JW, Ouyang LY, Liu XQ. Effect of magnesium isoglycyrrhizinate on PLA2 during liver tissue injury following limb ischemia\/reperfusion in rats. Zhonghua Gan Zang Bing Za Zhi. 2012;20:537\u201341.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"655_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000235873","volume":"84","author":"Y Cheng","year":"2009","unstructured":"Cheng Y, Zhang J, Shang J, Zhang L. Prevention of free fatty acid-induced hepatic lipotoxicity in HepG2 cells by magnesium isoglycyrrhizinate in vitro. Pharmacology. 2009;84:183\u201390.","journal-title":"Pharmacology"},{"key":"655_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1674-8301(10)60024-3","volume":"24","author":"Y He","year":"2010","unstructured":"He Y, Zeng F, Liu Q, Ju W, Fu H, Hao H, Li L, Xie Y. Protective effect of magnesium isoglycyrrhizinate on ethanol-induced testicular injuries in mice. J Biomed Res. 2010;24:153\u201360.","journal-title":"J Biomed Res"},{"key":"655_CR28","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/hep.27284","volume":"60","author":"V Sapp","year":"2014","unstructured":"Sapp V, Gaffney L, EauClaire SF, Matthews RP. Fructose leads to hepatic steatosis in zebrafish that is reversed by mechanistic target of rapamycin (mTOR) inhibition. Hepatology. 2014;60:1581\u201392.","journal-title":"Hepatology"},{"key":"655_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12986-015-0036-z","volume":"12","author":"W Dai","year":"2015","unstructured":"Dai W, Wang K, Zheng X, Chen X, Zhang W, Zhang Y, Hou J, Liu L. High fat plus high cholesterol diet lead to hepatic steatosis in zebrafish larvae: a novel model for screening anti-hepatic steatosis drugs. Nutr Metab (Lond). 2015;12:42.","journal-title":"Nutr Metab (Lond)"},{"key":"655_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nprot.2007.514","volume":"3","author":"C Thisse","year":"2008","unstructured":"Thisse C, Thisse B. High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protoc. 2008;3:59\u201369.","journal-title":"Nat Protoc"},{"key":"655_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/alcalc\/agr035","volume":"46","author":"J Chick","year":"2011","unstructured":"Chick J. The WHO global strategy to reduce the harmful use of alcohol. Alcohol Alcohol. 2011;46:223.","journal-title":"Alcohol Alcohol"},{"key":"655_CR32","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.4254\/wjh.v7.i27.2703","volume":"7","author":"S Llerena","year":"2015","unstructured":"Llerena S, Arias-Loste MT, Puente A, Cabezas J, Crespo J, F\u00e1brega E. Binge drinking: Burden of liver disease and beyond. World J Hepatol. 2015;7:2703\u201315.","journal-title":"World J Hepatol"},{"key":"655_CR33","first-page":"147","volume":"38","author":"NA Osna","year":"2017","unstructured":"Osna NA, Donohue TM Jr, Kharbanda KK. Alcoholic liver disease: pathogenesis and current management. Alcohol Res. 2017;38:147\u201361.","journal-title":"Alcohol Res"},{"key":"655_CR34","doi-asserted-by":"publisher","first-page":"7201","DOI":"10.1111\/jcmm.15230","volume":"24","author":"W Jiang","year":"2020","unstructured":"Jiang W, Xu S, Guo H, Lu L, Liu J, Wang G, Hao K. Magnesium isoglycyrrhizinate prevents the nonalcoholic hepatic steatosis via regulating energy homeostasis. J Cell Mol Med. 2020;24:7201\u201313.","journal-title":"J Cell Mol Med"},{"key":"655_CR35","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.bmc.2018.12.033","volume":"27","author":"C Xie","year":"2019","unstructured":"Xie C, Li X, Zhu J, Wu J, Geng S, Zhong C. Magnesium isoglycyrrhizinate suppresses LPS-induced inflammation and oxidative stress through inhibiting NF-\u03baB and MAPK pathways in RAW264.7 cells. Bioorg Med Chem. 2019;27:516\u201324.","journal-title":"Bioorg Med Chem"},{"key":"655_CR36","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.3892\/mmr.2017.6993","volume":"16","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, Tang Z, Zhang W, Liu J, Li B. Magnesium isoglycyrrhizinate protects against renal-ischemia-reperfusion injury in a rat model via anti-inflammation, anti-oxidation and anti-apoptosis. Mol Med Rep. 2017;16:3627\u201333.","journal-title":"Mol Med Rep"},{"key":"655_CR37","doi-asserted-by":"publisher","first-page":"12370","DOI":"10.3748\/wjg.v21.i43.12370","volume":"21","author":"GH Tang","year":"2015","unstructured":"Tang GH, Yang HY, Zhang JC, Ren JJ, Sang XT, Lu X, Zhong SX, Mao YL. Magnesium isoglycyrrhizinate inhibits inflammatory response through STAT3 pathway to protect remnant liver function. World J Gastroenterol. 2015;21:12370\u201380.","journal-title":"World J Gastroenterol"},{"key":"655_CR38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3892\/ijmm.2016.2603","volume":"38","author":"Q Xu","year":"2016","unstructured":"Xu Q, Wang J, Chen F, Lin K, Zhu M, Chen L, Zhou X, Li C, Zhu H. Protective role of magnesium isoglycyrrhizinate in non-alcoholic fatty liver disease and the associated molecular mechanisms. Int J Mol Med. 2016;38:275\u201382.","journal-title":"Int J Mol Med"},{"key":"655_CR39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2147\/DDDT.S115121","volume":"10","author":"Q Yang","year":"2016","unstructured":"Yang Q, Wang J, Liu R, Wang Z, Li Y, Zhang Y, Hao X, Huang Y, Xie W, Wei H. Amelioration of concanavalin A-induced autoimmune hepatitis by magnesium isoglycyrrhizinate through inhibition of CD4(+)CD25(-)CD69(+) subset proliferation. Drug Des Devel Ther. 2016;10:443\u201353.","journal-title":"Drug Des Devel Ther"},{"key":"655_CR40","doi-asserted-by":"publisher","first-page":"33252","DOI":"10.18632\/oncotarget.16629","volume":"8","author":"W Jiang","year":"2017","unstructured":"Jiang W, Liu J, Li P, Lu Q, Pei X, Sun Y, Wang G, Hao K. Magnesium isoglycyrrhizinate shows hepatoprotective effects in a cyclophosphamide-induced model of hepatic injury. Oncotarget. 2017;8:33252\u201364.","journal-title":"Oncotarget"},{"key":"655_CR41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/00498254.2016.1185195","volume":"47","author":"B Qu","year":"2017","unstructured":"Qu B, Xing R, Wang H, Chen X, Ge Q, Peng D, Wang G. Multiple effects of magnesium isoglycyrrhizinate on the disposition of docetaxel in docetaxel-induced liver injury. Xenobiotica. 2017;47:290\u20136.","journal-title":"Xenobiotica"},{"key":"655_CR42","doi-asserted-by":"publisher","first-page":"3526903","DOI":"10.1155\/2017\/3526903","volume":"2017","author":"Y Wang","year":"2017","unstructured":"Wang Y, Zhang Z, Wang X, Qi D, Qu A, Wang G. Amelioration of ethanol-induced hepatitis by magnesium isoglycyrrhizinate through inhibition of neutrophil cell infiltration and oxidative damage. Mediat Inflamm. 2017;2017:3526903.","journal-title":"Mediat Inflamm"},{"key":"655_CR43","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/iub.1639","volume":"69","author":"C Lu","year":"2017","unstructured":"Lu C, Xu W, Shao J, Zhang F, Chen A, Zheng S. Blockade of hedgehog pathway is required for the protective effects of magnesium isoglycyrrhizinate against ethanol-induced hepatocyte steatosis and apoptosis. IUBMB Life. 2017;69:540\u201352.","journal-title":"IUBMB Life"},{"key":"655_CR44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12929-015-0206-3","volume":"22","author":"X Zheng","year":"2015","unstructured":"Zheng X, Dai W, Chen X, Wang K, Zhang W, Liu L, Hou J. Caffeine reduces hepatic lipid accumulation through regulation of lipogenesis and ER stress in zebrafish larvae. J Biomed Sci. 2015;22:105.","journal-title":"J Biomed Sci"},{"issue":"Suppl 1","key":"655_CR45","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1111\/j.1440-1746.2007.05276.x","volume":"23","author":"C Ji","year":"2008","unstructured":"Ji C. Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic liver injury. J Gastroenterol Hepatol. 2008;23(Suppl 1):S16-24.","journal-title":"J Gastroenterol Hepatol"},{"key":"655_CR46","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jhep.2020.04.038","volume":"73","author":"Q Song","year":"2020","unstructured":"Song Q, Chen Y, Wang J, Hao L, Huang C, Griffiths A, Sun Z, Zhou Z, Song Z. ER stress-induced upregulation of NNMT contributes to alcohol-related fatty liver development. J Hepatol. 2020;73:783\u201393.","journal-title":"J Hepatol"},{"key":"655_CR47","doi-asserted-by":"publisher","first-page":"12563","DOI":"10.3390\/ijms140612563","volume":"14","author":"JJ Tsai","year":"2013","unstructured":"Tsai JJ, Kuo HC, Lee KF, Tsai TH. Glycyrrhizin represses total parenteral nutrition-associated acute liver injury in rats by suppressing endoplasmic reticulum stress. Int J Mol Sci. 2013;14:12563\u201380.","journal-title":"Int J Mol Sci"},{"key":"655_CR48","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jphotobiol.2015.05.003","volume":"148","author":"MR Farrukh","year":"2015","unstructured":"Farrukh MR, Nissar UA, Kaiser PJ, Afnan Q, Sharma PR, Bhushan S, Tasduq SA. Glycyrrhizic acid (GA) inhibits reactive oxygen species mediated photodamage by blocking ER stress and MAPK pathway in UV-B irradiated human skin fibroblasts. J Photochem Photobiol B. 2015;148:351\u20137.","journal-title":"J Photochem Photobiol B"},{"key":"655_CR49","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejphar.2017.05.032","volume":"809","author":"XJ Zhao","year":"2017","unstructured":"Zhao XJ, Yang YZ, Zheng YJ, Wang SC, Gu HM, Pan Y, Wang SJ, Xu HJ, Kong LD. Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-\u03baB\/NLRP3 inflammasome activation and lipid metabolism disorder. Eur J Pharmacol. 2017;809:141\u201350.","journal-title":"Eur J Pharmacol"},{"key":"655_CR50","doi-asserted-by":"publisher","first-page":"5884","DOI":"10.3390\/ijms22115884","volume":"22","author":"L Lu","year":"2021","unstructured":"Lu L, Hao K, Hong Y, Liu J, Zhu J, Jiang W, Zhu Z, Wang G, Peng Y. Magnesium isoglycyrrhizinate reduces hepatic lipotoxicity through regulating metabolic abnormalities. Int J Mol Sci. 2021;22:5884.","journal-title":"Int J Mol Sci"}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-022-00655-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-022-00655-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-022-00655-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T22:03:15Z","timestamp":1666735395000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionandmetabolism.biomedcentral.com\/articles\/10.1186\/s12986-022-00655-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["655"],"URL":"https:\/\/doi.org\/10.1186\/s12986-022-00655-7","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"27 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Animal Care and Use Committee of Southern Medical University, Guangzhou and every effort was made to minimize suffering.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No conflicts of interest were declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}